Growth characteristics of circulating hematopoietic progenitors in terminal renal failure

Medical Science Monitor

Volumn 12, Issue 3, 2006, Pages

  Glaser, Marjana ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

BFU E; CFU GEMM; CFU GM; Chronic renal failure; Circulating hematopoietic progenitors; Erythropoietin (EPO); Hemodialysis; Uremia

Indexed keywords

GROWTH FACTOR; METHYLCELLULOSE;

ADULT; AGED; ARTICLE; BLOOD; BURST FORMING UNIT E; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; GROWTH; HEMATOPOIETIC STEM CELL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; UREA BLOOD LEVEL;

ADULT; AGED; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; HEMATOPOIESIS; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL DIALYSIS;

EID: 33644679879     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. nd Ed: New York, Edinburgh, London: Churchil Livingstone, 1995; 255-86
2. Molecular biology and cytokines. In: Munker R, Hiller E, Paquette R, eds. Modern Hematology. Totowa, New Jersey, Humana Press, 2000; 19-34
3. Matsuzaki Y, Mizuguchi T, Kosaka M, Saito S: Analysis of circulating hematopoietic progenitors in patients with chronic renal failure under hemodialysis. Int J Hematol, 1995; 63: 33-40
4. Eschbach JW, Adamson JW, Cook JD: Disorders of red blood cell production in uremia. Arch Intern Med, 1970; 126: 812-15
5. Radtke HW, Rege AB, La Marche MB, Bartos D et al: Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure. J Clin Invest, 1981; 61: 1623-29
6. Meytes D, Bogin EMA, Dukex PP, Masry SG: Effect of parathyroid hormone on erythropoiesis. J Clin Invest, 1981; 67: 1263-69
7. rd Ed. Dordrecht, Boston, Lancaster, Kluwer Academic Publishers, 1989; 851-64
8. Means RT, Krantz SB: Progress in understanding the pathogenesis of the anemia in chronic disease. Blood, 1992; 80: 1639-47
9. nd Ed: New York, Edinburgh, London, Churchil Livingstone, 1995; 180-92
10. st century medicine. Med Sci Monit, 2001; 7(6): 1121-22
11. Ferrero D, Broxmeyer HE, Pagliardi GL et al: Antigenically distinct subpopulations of myeloid progenitor cells (CFU GM) in human peripheral blood and marrow. Proc Natl Acad Sci USA, 1983; 80(13): 4114-18
12. Labar B: Eritrocitopoeza, biokemija i funkcija eritrocita. In: Jakšić B, Labar B, Grgičević D, eds. Hematologija i transfuziologija. Zagreb, JUMENA, 1989: 23-32
13. Lertora JJL, Dargon P, Rega AB, Fischer JW: Studies on a radioimmunoassay for erythropoietin. J Lab Clin Med, 1975; 86(1): 140-51
14. Eschbach JW, Haley RN, Engrie JC, Adamson JW: A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney Int, 1992; 42: 407-16
15. Shannon JS, Lappin TRJ: The anemia in chronic renal failure. A potentially treatable catabolic phenomenon? Medical Hypotheses, 1986; 20: 29-36
16. Ganser A, Bergmann M, Volkers B et al: In vivo effects of recombinant human erythropoietin on circulating human hemopoietic progenitor cells. Exp Hematol, 1989; 17: 433-43
17. Zins B, Drueke T, Zingraff J et al: Erythropoietin treatment in anaemic patients on haemodialysis. Lancet, 1986; 2(8519): 1329
18. Eschbach JW, Egrie JC, Downing MR et al: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med, 1987; 316(2): 73-78
19. De Klerk G, Wilmink JM, Rosengarten PCJ et al: Serum erythropoietin titers in anemia of chronic renal failure. J Lab Clin Med, 1982; 100: 720-34
20. Pavletic Z, Labar B: Hematopoetski faktori rasta. Lijec Vjes, 1990; 112: 339-46
21. Morra L, Ponassi AG, Gurreri G et al: Inadequate ability of T lymphocytes from chronic uremic subjects to stimulate the in vitro growth of committed erythroid progenitors (BFU E). Acta Haematol, 1988; 79(4): 187-91
22. Girndt M, Sester M, Sester U et al: Molecular aspects of T and B cell function in uremia. Kidney Int, 2001; 59(78): 206-11
23. Bier V, Debantin KM, Bosh A et al: Is interleukin (IL 3) a critical haematopoietic growth factor in uremia? Proc Eur Congr Dial Transplant, Vienna, 1990
24. Corazza F, Bergmann P, Dratwa M et al: Responsiveness to recombinant erythropoietin therapy in end stage renal disease. An analysis of the predictive value of several biological measurements, including circulating erythroid progenitors. Nephrol Dial Tranplant, 1992; 7: 311-17
25. Allen DA, Breen C, Yaqoob MM, Mac Dougall IC: Inhibition of CFU E colony formation in uremic patients with inflammatory disease: role of IFN γ and TNF α. J Invent Med, 1999; 47(5): 204-11
26. Summerfield GP, Bellingham AJ: The effects of therapeutic dialysis and renal transplantation on uremic serum inhibitors of erythropoiesis in vitro. Brit J Haematol, 1984; 58: 295-304
27. Randall G, Meyer J, Swanepoel C, Jacobs P: Burst promoting activity in the serum of patients with chronic renal failure undergoing long term hemodialysis. Stem Cells, 1993; 11: 428-34
28. Hotta T, Maeda H, Suzuki I et al: Selective inhibition of erythropoiesis by sera from patients with chronic renal failure. Proc Soc Exp Biol Med, 1987; 186: 47-51
29. Zucker S, Lysik RM, Mohammad G: Erythropoiesis in chronic renal disease. J Lab Clin Med, 1976; 88(4): 528-35